期刊文献+

细胞间隙蛋白在乳腺癌中的研究进展 被引量:2

Advanced research on the connexins in breast cancer
下载PDF
导出
摘要 乳腺癌在女性恶性肿瘤发生中占据第一,细胞间隙蛋白家族被视为抑癌基因,在乳腺癌的增殖、侵袭和转移及化疗耐药中起重要的作用。本文主要讨论细胞间隙蛋白在乳腺癌中的研究进展,进而寻找细胞间隙蛋白与信号通路间的共通点,为乳腺癌的治疗打开新的研究方向。 Breast cancer has taken the first place in the women's malignant tumors. Connexin gene family is regarded as a tumor suppressor, playing an important role on the proliferation, invasion, metastasis and chemoresistenee of breast cancer. This review assesses our current understandings of the connexins and we want to find some common points with signaling pathways in order to open new research directions.
作者 傅韵 庄志刚
出处 《现代肿瘤医学》 CAS 2012年第9期1953-1956,共4页 Journal of Modern Oncology
基金 上海市卫生局青年项目(编号:20114y155) 上海市申康前沿课题(编号:SHDC12010116)
关键词 细胞间隙蛋白 细胞间隙通讯 乳腺癌 化疗耐药 connexin GJIC breast cancer chemoresistance
  • 相关文献

参考文献25

  • 1Mese G, Richard G, White TW. Gap junctions: basic structure and function[ J]. J Invest Dermatol, 2007,127:2516 - 2524.
  • 2Laird DW. The gap junction proteome and its relationship to dis- ease[ J]. Trends Cell Biol, 2010,20:92 - 101.
  • 3Mclachlan E, Shao Q, Laird DW,et al. Connexins and gap junc- tions in mammary gland development and breast cancer progression [J]. JMembrBiol, 2007,218(1-3):107-121.
  • 4Pozzi A, Risek B, Kiang DT, et al. Analysis of muhiple gap junc- tion gene products in the rodent and human mammary gland [ J ]. Exp Cell Res ,1995, 220( 1 ) :212 -219.
  • 5Solan JL, Lampe PD. Connexin 43 phosphorylation: structural changes and biological effects[ J ]. Bioehem J, 2009,419 : 261 - 272.
  • 6Gilleron, J,Fiorini C, Carette D,et al. Molecular reorganization of Cx43, Zo - 1 and Sre complexes during the endocytosis of gap junction plaques in response to a non - genomic carcinogen [ J ]. J Cell Sei ,2008, 121:4069 - 4078.
  • 7McLaehlan E, Shao Q, Laird DW. Connexins and gap junctions in mammary gland development and breast cancer progression [ J ]. JMembrane Biol, 2007, 218 : 107 - 121.
  • 8Locke D, Kieken F, Tao L,et al. Mechanism for modulation of ga- ting of connexin26 - containing channels by taurine [ J ]. J Gen Physiol, 2011, 138(3) :321 -339.
  • 9Cronier L, Crespin S, Strale PO, et al. Gap junctions and cancer: new functions for an old story [ J ]. Antioxid Redox Signal, 2009, 11:323 - 338.
  • 10Kanczuga- Koda L, Sulkowski S, Lenczewski A, et al Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer[ J]. J Clin Pathol, 2006, 59:429 -433.

二级参考文献11

  • 1张伟.生物荧光肿瘤体外药敏检测技术的临床应用及其探讨[J].癌症进展,2005,3(5):427-435. 被引量:12
  • 2胡叶青,刘元姣.Cx43、Skp2在卵巢上皮性肿瘤组织中的表达及临床意义[J].癌症,2005,24(1):104-109. 被引量:17
  • 3Bao X, Altenberg GA, Reuss L Mechanism of regulation of the gap junction protein connexin 43 by protein kinase C-mediated phosphorylation. Am J Physiol Cell Physio1,2004,286 : 647-654.
  • 4Nemeth L, Rolle U, Puri P. Altered cytoskeleton in smooth muscle of aganglionic bowel. Arch Pathol Lab Med,2002,126:692-696.
  • 5Fernstrom MJ, Koffler LD, Abou-Rjaily G, et al. Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43. Exp Mol Pathol,2002 ,73 :54-60.
  • 6Toler CR, Taylor DD, Gercel-Taylor C. Loss of communication in ovarian cancer. Am J Obstet Gynecol,2006,194 : e27-31.
  • 7Femandes R, Gir~o H, Pereira P. High glucose down-regulates intercellular communication in retinal endothelial ceils by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem,20(M ,279:27219-27224.
  • 8Neumann ID, Torner L, Toschi N, et al. Oxytocin actions within the supraoptic and paraventricular nuclei: differential effects on peripheral and intranuelear vasopressin release. Am J Physiol Regul IntegT Comp Physio1,2006,291:29-36.
  • 9Gould VE, Mosquera JM, Leykauf K, et al. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries. Hum Pathol, 2005, 36 : 536-545.
  • 10Hasegawa J, Takekoshi S, Nagata H, et al. Sevoflurane stimulates MAP kinase signal transduction through the activation of PKC alpha and beta Ⅱ in fetal rat cerebral cortex cuhured neuron. Acta Histochem Cytochem ,2006,39 : 163-172.

共引文献5

同被引文献12

  • 1Budhu A, Ji J, Wang XW. The clinical potential of microRNAs. J Hematol Oncol ,2010, 3:37.
  • 2Goldhirsch A, Wood WC, Coates AS . Strategies for subtypes- dealing with the diversity of breast cancer: llighlights of the St. Gallen International Expert Consensus on the Primal' Therapy of Early Breast Cancer 2011 . Ann Oncol,2011 ,22 : 1736-1747.
  • 3Hidaka H, Seki N, Yosifino H , et al. Tmnor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional siguifieance in renal cell carcinoma. Oncotarget, 2012,3:44-57.
  • 4Vickers MM, Bar J, Gom-Hondermann I, et al. Stage-dependent differential expression of microRNAs in colorectal cancer:potential role as markers of metastatic disease. Clin Exp Metastasis,2012 , 29 : 123-132.
  • 5Zhang T, Lia M, Wang C, et al. Down-regu|ation of Hsa-miR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res, 2011,31 : 3859- 3863.
  • 6Chen X, Yan Q, Li S, et al. Expression of the tumor suppressor hsa-miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERa-positive endometfioid adenocarcinoma. Cancer Lett, 2012 ,314:41-53.
  • 7Kondo N, Toyama T, Sugiura H, et al. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res, 2008, 68:5004-5008.
  • 8Yang L, Wu X, Wang Y, et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene, 2011 , 30 : 4437 4446.
  • 9Stratford AL, Reipas K, Hu K,et al. Targeting p90 ribosonml $6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-I in triple-negative breast cancers. Stem Cells, 2012 ,30:1338-1348.
  • 10Chen X, Xu Z, Wang Y. Recent advances in breast cancer metastasis suppressor 1. Int J Biol Markers,2011,26:1-8.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部